Anti-cancer therapies

Details for Australian Patent Application No. 2005213372 (hide)

Owner Threshold Pharmaceuticals, Inc.

Inventors Tidmarsh, George

Agent Spruson & Ferguson

Pub. Number AU-B-2005213372

PCT Pub. Number WO2005/076888

Priority 60/542,494 06.02.04 US

Filing date 4 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 24 March 2011

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/076888 Priority application(s): WO2005/076888

24 March 2011 Application Accepted

  Published as AU-B-2005213372

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005213374-Approach for estimating user ratings of items

2005213362-Method and apparatus for unloading ribbon rails from rail cars